Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium

PURPOSE: In 75% of ovarian cancer patients the tumor mass is completely eradicated by established surgical and cytotoxic treatment; however, the majority of the tumors recur within 24 months. Here we investigated the role of circulating tumor cells (CTCs) indicating occult tumor load, which remains...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Obermayr, Eva, Bednarz-Knoll, Natalia, Orsetti, Beatrice, Weier, Heinz-Ulrich, Lambrechts, Sandrina, Castillo-Tong, Dan Cacsire, Reinthaller, Alexander, Braicu, Elena Ioana, Mahner, Sven, Sehouli, Jalid, Vergote, Ignace, Theillet, Charles, Zeillinger, Robert, Brandt, Burkhard
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739744/
https://ncbi.nlm.nih.gov/pubmed/29290959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22468
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы